Dexamethasone in hospitalised patients with COVID-19: addressing uncertainties.

Matthay, Michael A; Thompson, B Taylor

Matthay, Michael A; Thompson, B Taylor.

Matthay MA; Cardiovascular Research Institute, Departments of Medicine and Anesthesia, University of California, San Francisco, CA 94143, USA. Electronic address: michael.matthay@ucsf.edu.
Thompson BT; Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

Lancet Respir Med ; 8(12): 1170-1172, 2020 12.

Article in English | MEDLINE | ID: covidwho-894320

Subject(s)

COVID-19 Drug Treatment; Dexamethasone/administration & dosage; Glucocorticoids/administration & dosage; Dexamethasone/adverse effects; Glucocorticoids/adverse effects; Humans; Pandemics; Pragmatic Clinical Trials as Topic; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Dexamethasone / COVID-19 Drug Treatment / Glucocorticoids Type of study: Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: Lancet Respir Med Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google